• FIGS (NYSE: FIGS) has entered an exclusive uniform partnership with European Wax Center for its Wax Specialists via the FIGS TEAMS platform.
• The arrangement focuses on supplying standardized professional apparel across European Wax Center locations, expanding FIGS' reach beyond its core healthcare customer base.
• This collaboration uses the TEAMS offering as a dedicated channel for outfitting EWC staff across the franchise network.
• The FIGS and European Wax Center uniform agreement reflects how FIGS is pushing TEAMS into broader service professions beyond medical settings. We have also flagged 1 other big win for FIGS.

This push into professional uniforms is not unique to FIGS, and several other listed companies are also tied into healthcare technology and services exposure via 36 healthcare AI stocks.

FIGS, a US-based direct-to-consumer healthcare apparel and lifestyle company with a market cap of about $3.3b, is using its TEAMS platform to reach workers in adjacent service roles who rely on consistent, branded uniforms.

Does the team leading FIGS have what it takes? See our full breakdown of the management team's track record and compensation.

FIGS TEAMS win with European Wax Center leans into the bull story, but execution risk stays front and center

This European Wax Center deal reinforces a key bullish pillar of the FIGS Narrative. TEAMS is one of the expansion levers analysts focus on alongside international and non scrubwear categories. This agreement shows the uniform model carrying into adjacent service roles beyond hospitals and clinics. For investors, the news helps confirm that FIGS can target more of the broader uniform wallet, not just the roughly US$550 that healthcare professionals are reported to spend each year, while still keeping the direct to consumer engine and margin discipline in view.

See how these catalysts shape FIGS' path to a $19.50 fair value.

The real test comes over the next few quarters as TEAMS revenue and order volume are reported. If FIGS starts to break out TEAMS traction in disclosures, or comments on a growing roster of similar partnerships on earnings calls, that would either validate this broader use case or signal that execution on the B2B catalyst is proving harder than the bullish Narrative assumes.

Add FIGS to your Watchlist and get alerts as these catalysts play out.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.